Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BIVIthis companyBioVie Inc.	$1.34	-0.64×	0×	0×	397,772.85×	87659892.5%	0.0%	0.0%	0.0%	-0.0%	-0.0%	-135339.5%	0.03×	397,773.5×	-1,265.39×	3.59×	0.0%	2	-39.28	3	B
ARTLArtelo Biosciences, Inc.	$2.03	-0.22×	-2.26×	0×	-0.24×	-565.9%	0.0%	0.0%	0.0%	1012.5%	1919.9%	-296.4%	-0.53×	-0.01×	-58.78×	0.17×	0.0%	2	-17.34	2	C+
ELABPMGC Holdings Inc.	$1.61	-0.38×	0.37×	4.9×	-0.02×	40235.4%	12.7%	-1250.1%	-1306.3%	-98.4%	-70.2%	-220.7%	0.34×	0.38×	-13.48×	1.74×	0.0%	3	-1.94	2	C
TOVXTheriva Biologics, Inc.	$0.16	-0.1×	0.17×	0×	0.33×	589.3%	0.0%	0.0%	0.0%	-164.1%	-52.1%	-653.9%	0.17×	0.44×	0×	1.74×	0.0%	2	-15.46	2	B-
Peer median	—	-0.22×	0.17×	0×	-0.02×	589.3%	0.0%	0.0%	0.0%	-98.4%	-52.1%	-296.4%	0.17×	0.38×	-13.48×	1.74×	0.0%	2	-15.46	2	—